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(international responses to poliomyelitis outbreaks in the 20th century), we explore the main 
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1.	 Introduction (*)
«For seventy years, polio traumatized the world» 1. Mark Shell begins his 
well-known monograph on the disease with these words, with which he 
sought to give an idea of the feelings of fear of its terrible consequences 
and the lack of effective remedies to hold it back in the first half of the 20th 
century and even later. If the problem of polio was a world-wide problem, 
especially concentrated in western countries, the hopes raised by the appea-
rance of the first effective vaccines were also world-wide. The globalization 
of preventive activities, including the active immunization of populations 
against infectious diseases such as poliomyelitis, remains a challenge and 
an objective to be achieved. The inception of responses to this disease at 
the international level has yet to be studied in its entirety.
The emergence of poliomyelitis outbreaks in the middle of the twentieth 
century, with special intensity in developed Western countries, led to a series 
of scientific meetings of virologists, epidemiologists, paediatricians and public 
health workers. The most significant activities related to infantile paralysis 
were the following: a) the birth of the World Polio Congresses in 1948, b) 
the reports of experts promoted by the World Health Organization, c) the 
conferences promoted by the European Association against Poliomyelitis, 
and d) the systematic introduction of monographic sessions in national 
and international paediatric congresses. One of the main aims of all these 
activities was to seek international consensus on: technical procedures 
in laboratory settings for the preparation of poliovirus cultures, the use 
of different types of vaccines in public health programmes, the design of 
publicity campaigns, the organization of rehabilitation services for polio 
patients, and the use of natural physical agents as therapeutic measures, 
among other issues.
  (*)  This research was supported by the Spanish Ministry of Science Project (HAR2009-14068-C02-
01) called «Enfermedades emergentes y comunidades de pacientes» and by the Consejería 
de Educación-JCCM Project (PII1I09-0114-0843) entitled «La asistencia antipoliomielítica en 
España en el  siglo XX  (los casos de Madrid, Valencia y Castilla-La Mancha): aspectos médi-
cos,  sociales  y  políticos».  A  preliminary  version  of  this  paper was  presented  at  the  EAHM 
Conference on «Global Developments and Local Specificities in the History of Medicine and 
Health» (Heidelberg, 3-6 September 2009).
  1.  Shell, Marc. Polio and its aftermath. The paralysis of culture. Cambridge: Harvard U.P; 2005.
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The first years of the 21st century have seen an increase in the histo-
riography devoted to International Health 2, which includes an in-depth 
analysis of the birth of some of the main international agencies and the 
role they played in the transformation observed in the approach to In-
ternational Health problems from the earliest International Health Con-
ferences in the 19th century up to the creation of the WHO. It has been 
shown how the figure of the «expert» emerged and acquired importance 
in the field of International Health. There have also been studies on some 
of these international agencies in specific countries and their approach to 
certain health problems 3 and on their relationships with and influence 
on the countries’ health authorities 4. However, no analysis has yet been 
made of the role that these international agencies may have played in the 
design and implementation of strategies against the epidemic presence 
of poliomyelitis in Europe after the Second World War. No studies have 
addressed the Spanish participation (if any) in this fight against the disea-
se, and this is the aim of the present paper 5. Our initial approach here 
centres on two aspects. First, an analysis of the main contents of technical 
reports and international conferences on poliomyelitis between 1948 and 
1960s and, in general terms, the most important strategies and policies in 
  2.  A  thought-provoking work on the concepts of «International Health» and «Global Health», 
and  the  role played by  the WHO  in  the  transition  from one  to  the other,  is  that of Brown, 
Theodore M.; Cueto, Marcos; Fee, Elizabeth. The World Health Organization and the transition 
from «international» to «global» health. In: Bashford, Alison, ed. Medicine at the border. New 
York: Palgrave Macmillan; 2006, p. 76-94.
  3.  Among the abundant bibliography, we can mention: Borowy, Iris. Coming to terms with world 
health.  The  League  of  Nations  Health  Organisations,  1921-1946.  Frankfurt  am Main:  Peter 
Lang; 2009. Rodríguez-Ocaña, Esteban, ed. The politics of healthy life. An international per-
spective. Sheffield: EAHMH; 2002. Barona, Josep Lluis. Nutrition and Health. The international 
context during the  interwar crisis. Social History of Medicine. 2008; 21  (1): 87-105. Borowy, 
Iris. Serological and biological standardisation at the League of Nations Health Organisation, 
1921-1939.  In:  Bonah,  Christian  et  al.,  eds.  Harmonizing  drugs.  Standards  in  20th-century 
pharmaceutical history. Paris: Editions Glyphe; 2009, p. 203-220.
  4.  For the Spanish case, see: Rodríguez Ocaña, Esteban. Foreign expertise, political pragmatism 
and professional elite: The Rockefeller Foundation  in Spain, 1919-1939. Stud. Hist. Phil. Bio. 
& Biomed. Sci. 2000; 31: 447-461 and Barona, Josep Lluis; Bernabeu-Mestre, Josep. La salud 
y el Estado. La administración española y el movimiento sanitario internacional (1851-1945). 
Valencia: PUV; 2008, which is very useful, and includes a comprehensive bibliography on this 
subject.
  5.  In other works in progress, we have begun to make a more detailed analysis of any connec-
tion between  international  strategies  and  those  set  in motion  in  Spain  to  fight  against 
polio. 
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the international setting. Second, we attempt to determine the role played 
in these international events by researchers and other figures involved in 
Spanish health policies 6.
This paper is part of a wider study that aims to offer a historical model 
of how scientific international developments and public health advice —uni-
versal in design— were received and implemented (or not implemented) 
in local settings and how local traditions and circumstances influenced 
final outcomes 7. In fact, polio may be seen as an excellent field trial for 
the application of certain concepts from social sciences, including «policy 
transfer», a process by which knowledge about policies, administrative 
arrangements, institutions and ideas in one political setting is used in the 
development of policies, administrative arrangements, institutions and ideas 
in another field 8. The case study will focus on Spain during the period of 
Franco’s dictatorship.
  6.  A wide range of recent research has focused on international health work, the role played by 
Spanish figures and institutions, and foreign influences from the Rockefeller Foundation or 
the LNHO. The following dossier from Dynamis included papers on Spain: Rodríguez-Ocaña, 
Esteban; Zylberman, Patrick, eds. Improving public health amidst crisis: the interwar years in 
Europe. Dynamis. 2008; 28: 9-198; the latest synthesis by Barona, Bernabeu-Mestre, n. 4.
  7.  Some recent papers published on polio epidemics in Spain are as follows: Ballester, Rosa et al. 
Vivencias personales y experiencias colectivas en  torno a  la poliomielitis en España  (1930-
1975).  In:  Ortiz,  Teresa  et  al.,  coord.  La  experiencia  de  enfermar  en  perspectiva  histórica. 
Granada: Universidad de Granada; 2008, p. 313-343; a monographic issue of Asclepio, coor-
dinated by José Martínez Pérez, included the following papers: Báguena, María-José. Estudios 
epidemiológicos y virológicos sobre la poliomielitis en Valencia (1959-1969). Asclepio. 2009; 
61 (1): 39-54; Ballester, Rosa; Porras, María-Isabel. El significado histórico de las encuestas de 
seroprevalencia como tecnología de laboratorio aplicada a  las campañas de inmunización. 
El caso de la poliomielitis en España. Asclepio. 2009; 61 (1): 55-80; Rodríguez Sánchez, Juan 
Antonio; Seco Calvo,  Jesús. Las campañas de vacunación contra  la poliomielitis en España 
en  1963.  Asclepio.  2009;  61  (1):  81-116; Martínez  Pérez,  José.  Presentación:  la  poliomielitis 
como modelo  para  el  estudio  de  la  enfermedad  en  perspectiva  histórica.  Asclepio.  2009; 
61  (1): 7-21; Martínez Pérez,  José. Consolidando el modelo médico de discapacidad:  sobre 
la  poliomielitis  y  la  constitución  de  la  traumatología  y  ortopedia  como  especialidad  en 
España  (1930-1950).  Asclepio.  2009;  61  (1):  117-142;  Báguena,  María-José;  Porras,  María-
Isabel; Ballester, Rosa. Poliomyelitis  in  rural and urban Spain: Epidemiological  trends,  social 
and scientific  responses.  In: Barona, Josep Lluis; Andresen, Astri; Cherry, Steve, eds. Making 
a new countryside? Bern:  Peter  Lang Verlagsgruppe;  2010, p.  115-134;  Rodríguez Sánchez, 
Juan Antonio et al. A poliomielitis na Peninsula  Iberica. Reflexões para a sua compreensão 
histórica. Coimbra: Universidade da Coimbra (in press).
  8.  Dolowitz, David P.; Marsh, David. Learning from abroad. The role of policy transfer in contem-
porary policy-making. Governance. 2000; 13: 5-24. An interesting approach on health is that 
of Berridge, Virginia. Travelling policies and policy transfer in health since the 1970´s: drugs, 
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The main historical sources used are the following: 1) Four Technical 
Reports on Poliomyelitis (1954-1960) by the WHO Committee of Experts; 
2) Proceedings of the European Symposia promoted by the European As-
sociation against Poliomyelitis (1948-1966); 3) Proceedings of the World 
Polio Congresses (1948-1960) and 4) Spanish sources: both official and 
professional documents.
First of all, we need to understand the foreign affairs situation and 
the global political issues within the international system involving Spain 
between 1940 and 1970 as well as the role played by polio in these ques-
tions. We then need to analyze the framework of health policies related to 
polio as carried out by international agencies (e.g., the WHO and European 
Association Against Polio) or by the institutions behind the organization 
of international congresses on polio.
2.	 The	 difficult	 international	 relations	 of	 Franco’s	 regime	 and	 polio	
outbreaks
Apart from some isolated outbreaks before the Spanish Civil War, such as 
the Madrid epidemic in 1929, polio was contemporary with the Francoist 
regime. Regarding foreign policy, Spain moved from international isolation 
and exclusion from the UN and all its organizations, to gradual incorporation 
from 1950 onwards into agencies such as FAO, UNESCO, WHO, UNICEF 
and ILO and, finally, to permanent membership of the UN in 1955. However, 
this «rehabilitation» of the Francoist regime was limited and caused mis-
givings in Western countries as well as involving tremendous political and 
economic costs. The polio epidemics paradoxically represented a kind of 
legitimization of the regime, given its character as a «disease of civilization» 9, 
harm reduction and HIV. Conference of the European Association for the History of Medicine 
and Health. Heidelberg, 2009 (unpublished).
  9.  As  has  recently  been  pointed  out  by  Axelsson,  the  prevailing  current  explanation  for  the 
transformation of polio  from an uncommon disease  to a  feared epidemic emphasizes  the 
importance of improvements in hygiene and sanitation. Before the late 19th century, all infants 
were exposed to the common virus but maternal antibodies  that  led to  lifelong  immunity 
against polio protected them. However, sanitation improvements in some western countries 
provided  a  healthier  environment  and made  the  virus  less  common.  Consequently  fewer 
infants were exposed  to  the virus. This  increased  the proportion of unexposed  individuals 
susceptible to polio later  in life. Moreover,  improvements in hygiene were most often initi-
ated  in  areas  of  relatively  high  living  standards. This made  the higher  social  classes  those 
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a disease of developed countries where sanitary measures avoided contact 
of the young with the virus and therefore prevented them from developing 
immunity. To emphasize the close relationship between development and 
poliomyelitis that we have just mentioned, Payne launched a new hypothesis 
that endowed epidemiological data and serological surveys with the value 
of indicators: as the rates of infant mortality in a given geographical area 
show a tendency to fall, the incidence and prevalence of polio will increa-
se (the Payne effect). This idea was used as a political argument in some 
countries and also, particularly, in Spain. Numerous witnesses agreed —in 
the words of one of the authorities of the time: «as in almost all countries 
with a high standard of health, in Spain poliomyelitis tends to increase at 
the same time as infant mortality tends to fall» 10.
Therefore, in spite of the internal disputes within the different factions 
of the regime on how to cope with the epidemics and how to transmit health 
information to the population, efforts were made from the very beginning 
to attend international forums at which the issues surrounding polio were 
discussed. The participation of a country with an antidemocratic regime 
and low international standing in these scientific meetings meant a great 
deal to the political authorities.
3. The WHO poliomyelitis programme
Evidence of interest in poliomyelitis appears in the earliest documents 
of the international organization. At the First World Health Assembly 
of 24 July 1948, within the section on «Virus Diseases», a proposal was 
presented by the French Delegation on Acute Anterior Poliomyelitis, due 
to the increase in severe forms of polio in numerous countries that «had 
reached disquieting proportions» 11. One of the most important issues 
discussed was that polio should be studied on an international basis, in 
most  susceptible  to  the  virus.  For  this  reason,  polio  was  considered  a  disease  caused  by 
civilization. Axelsson, Per. Höstens spöke. De svenska polioepidemiernas historia. Stockholm: 
Carlsson; 2004 [Swedish text with a summary in English], p. 230-238.
 10.  Bosch Marín, Juan; Bravo, Enrique. Aportación de España a la lucha contra la poliomielitis. In: 
Aportación española al V Symposium europeo sobre poliomielitis (Madrid, 28-30 September 
1958), Madrid: Publicaciones «Al servicio del niño español», Mº de la Gobernación; 1958, p. 
45-51.
 11.  World Health Organisation. First World Health Assembly. Eleventh meeting. 1948, p. 143.
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close collaboration between epidemiologists and laboratory and clinical 
experts: «The disease lent itself to study by visiting teams. The present 
approaches were highly expensive for small countries —in particular the 
use of monkeys for experimental purposes— and the problem could best 
be studied by international action».
The final resolution of the Health Assembly was the following:
«The appropriate division of the Secretariat shall be immediately instructed 
to conduct an investigation into poliomyelitis, and recommends:
(1) that such studies shall be based upon the first results achieved by 
the Brussels and New York Conferences and shall pave the way for the future 
work of similar conferences, which should receive the support and encoura-
gement of the WHO.
(2) that a report, in the form of a restatement of this important question, 
shall be submitted to the second Health Assembly» 12.
The words quoted above clearly show the WHO’s interest in polio-
myelitis from the very start of its operations in 1948; but it also shows 
how the research into the disease by the WHO was closely linked to the 
activities undertaken that year against polio on a world-wide and Europe-
wide basis. As we shall see later, the Brussels and New York Conferences 
respectively constituted the embryos of the future European Association 
against Poliomyelitis and the First International Poliomyelitis Conference. 
Both initiatives were set in motion with the intention of fighting against 
poliomyelitis, which emerged as an important public health issue in the 
Western world after the Second World War. The extent to which the WHO 
committed itself to cooperate with and support both initiatives in its First 
World Health Assembly is also clear.
From 1953 onwards, the WHO also included polio among its own 
priorities, probably because of the weight in the Organization of severely 
affected countries that were investing substantial human and economic 
resources in research, as was the case of the USA and some European 
countries. The Third World Health Assembly stressed the desirability of 
international guidance on measures to be taken to prevent the spread of 
poliomyelitis. It recommended the establishment of a committee of experts 
to co-ordinate research, with a view to obtaining the information necessary 
 12.  World Health Organisation, n. 11.
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to specify effective preventive measures. The first session of the Committee 
was held in Rome from 14 to 19 September 1953, immediately after the 
Sixth International Congress of Microbiology.
The specific means by which the WHO became involved in the 
question of polio was thus the common way to deal with this type 
of problem. For advice on more technical questions, the Secretariat 
headquarters appointed a panel of experts, from which were selected 
Committees of Experts to recommend policies 13. Between 1953 and 
1960 the executive board, whose functions included the setting up of 
these Committees of Experts 14, appointed several specific committees 
to deal with the subject of polio. The importance given to the question 
was further demonstrated when the meetings of the committees were 
published in the form of reports, sanctioned and approved by the Ge-
neral Assembly; this only happened in cases which were considered to 
be highly important and required international diffusion. These reports 
were published either partially or in their entirety. In the case of polio, 
all reports were published in their entirety.
The Committees of Experts were (and still are) the key to the workings 
of the Organization. Their purpose was to give technical advice on particular 
questions. The reports, of which four were published between 1953 and 
1960, did not necessarily express the view of the Organization, but they 
were an essential tool in forming policies and preparing programmes.
Individual members were appointed on their own merit, not as repre-
sentatives of governments, institutions or associations, although efforts 
were made to ensure some geographical spread. The criterion of compe-
tence rather than nationality led to a kind of trans-national community 
of experts 15 with roots in the international public health movements of 
organizations founded prior to the setting up of the WHO, such as the 
Office International d’Hygiène Publique (OIHP).
Who were the members of the Expert Committee on Polio? Two mem-
bers of the Secretariat were key figures in the early history of the WHO: 
 13.  Roemer, Milton I. Internationalism in medicine and public health. In: Bynum, William F.; Porter, Roy, 
eds. Encyclopaedia of the History of Medicine. London: Routledge; 1993, p. 1427-1429.
 14.  World Health Organisation. Constitution of the World Health Organisation. Chapter VIII, art. 
38-40. 1946.
 15.  Solomon, Susan Gross; Murard, Lion; Zylberman, Patrick. Shifting boundaries of public health. 
New York: University of Rochester Press; 2008, p. 6-8.
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W. Bonne, director of the Division of Communicable Diseases and A. 
Payne, professor and chairman of the Department of Epidemiology and 
Public Health, Yale University School of Medicine, formerly Chief Medical 
Officer for virus diseases. The other experts on the committees varied 
over time. The total number of committee members fluctuated between 
10 and 15. Of the permanent members, four appeared in each and every 
one of the Reports. Three were from the field of experimental laboratory 
research: Sven Gard from Sweden, John Gear from South Africa, and the 
Head of the Virus Service of the Institut Pasteur, Pierre Lépine, probably 
the most important virologist of his time. The fourth, the professor of 
preventive medicine at the Yale University School of Medicine, John Paul, 
was a key figure in the history of polio and author of the first history of 
the disease 16; he acted as chairman. The remaining members depended 
on the content of each report and on the importance of a particular issue 
at any given time. For instance, the epidemiologist Thomas Francis 17 
appeared in the First Report of 1954, at a time when preparations were 
in hand for the clinical trials of the Salk vaccine, carried out under his 
direction in April 1955. Likewise, Albert Sabin, professor of paediatric 
research at the University of Cincinnati and creator of the oral polio 
vaccine (OPV), was invited to take part in the Reports of 1956 and 1958 
when the scientific forums were discussing anti-polio vaccines and research 
on inactivated vaccines and attenuated live virus vaccines.
3.1.	The	contents	of	the	Reports
Between the first report of the Expert Committee (1954), which dealt with 
the general aspects of the disease (causal agents, acute clinical symptoms, 
laboratory methods and general and non-specific preventive measures) 18 
and the second report in 1958 19, a series of important advances in research 
made it necessary to publish a monograph on the new vaccination proce-
 16.  Paul, John. A history of poliomyelitis. New Haven: Yale University Press; 1971.
 17.  Monto, Arnol. Francis trial on  inactivated poliomyelitis vaccine background and  lessons for 
today. Epidemiological neviews. 1999; 21(1): 7-23..
 18.  World Health Organisation. Expert Committee on Poliomyelitis. First Report. Geneva: World 
Health Organisation [Technical Reports, nº. 81]; 1954.
º 19.  World Health Organisation. Expert Committee on Poliomyelitis. Second Report. Geneva: World 
Health Organisation [Technical Reports, nº. 145]; 1958.
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dures. Above all, there was exceptional interest in the mass media about 
the widespread clinical trials carried out by the epidemiologist Thomas 
Francis with Jonas Salk’s injected polio vaccine (IPV) 20. Its success in the 
USA encouraged other research teams from different countries to prepare 
vaccines with inactivated viruses.
However, the committee believed that the general prophylactic mea-
sures (except active immunization with convalescents’ serum) listed in the 
first report retained all their value. These measures included the following: 
notification of polio cases, isolation and care of the patients, protection of 
families and collectives exposed to the infection, and appraisal of the risk 
of paralysis as a consequence of both vaccinations and surgical procedures. 
The production of vaccines continued to pose problems and difficulties 
that required rigorous and constant surveillance of the preparation pro-
cedures.
The decision to undertake or intensify a vaccination campaign was 
the competence of the national authorities, who best understood the im-
portance of poliomyelitis in comparison with other urgent public health 
problems in each country. Polio vaccination might be more suitable in some 
countries than in others. It was necessary to carry out, in each country, an 
in-depth study of the background of the problem and to attempt to foresee 
its evolution over the next ten years. The first signs of the imminence of 
an outbreak were as follows: a) decrease in infant mortality to below 75 
deaths per 1,000 children and 2) the appearance of polio cases not only 
among breast-fed babies but also in older children. When at least 20% of 
victims were over ten years of age, an intensification of the disease could 
be expected.
On the other hand, it was considered of great importance to keep full 
records that provided information on doses and dates of inoculation plus 
a statement on possible adverse reactions.
The fourth and final meeting of the Expert Committee during this 
period took place in Washington in June 1960 21. It was held in a mood of 
optimism as a result of the potential of oral polio vaccine (OPV) for the 
mass immunization of the population and the effectiveness of the vaccine, 
 20.  World Health Organisation. Expert Committee on Poliomyelitis. The vaccination against polio. 
Preliminary exam. Geneva: World Health Organisation [Technical Reports, nº. 101]; 1956.
 21.  World Health Organisation. Expert Committee on Poliomyelitis. Third Report. Geneva: World 
Health Organisation [Technical Reports, nº. 203]; 1960.
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which caused a sharp fall in morbidity rates in countries in which it was 
used. In the majority of countries, it was decided to immunize with the oral 
vaccine, since it was cheaper, easier to administer and allowed collective 
immunity to be given to the population. 
Spain played no part at all in any of the four reports. There was not a 
single Spanish representative on the committees and subcommittees, not 
even as «temporary adviser», and there is no information on epidemiological 
data or any activities being carried out. This information was available for 
a large number of countries, some geographically smaller and with sma-
ller populations than Spain. However, this is consistent with the Franco 
regime’s reluctance to admit the presence of disease and the circumstances 
of isolation during the early years of the dictatorship. It should be borne 
in mind that Spain was excluded from the WHO until 1951. Although this 
exclusion may be explained by the regime’s political ideology, we agree with 
Barona and Bernabeu in also relating it to the setbacks suffered by Spanish 
public health after the Civil War, due to the exile and repression of health 
professionals 22. In fact, two of the exiled republicans —Marcelino Pascua 
(1897-1977) and Santiago Ruesta Marco (1899-1960)— formed part of the 
WHO as experts and played a significant role in the organization. Marce-
lino Pascua arrived in the organisation in 1948 as a health statistician and 
retired in 1966 after almost ten years as consultant to the Director General 
of WHO 23. Nevertheless, as we shall show, it would not be until 1958 that 
Florencio Pérez Gallardo (1917-2006), director of the Laboratory of Virology, 
National Health School (Madrid), represented the WHO as delegate of the 
European Regional Office in the V Symposium of the European Association 
against Poliomyelitis.
What repercussions did the warnings and recommendations of the WHO 
have in Spain? We are probably still not in a position to make a detailed 
report, but we see a health administration with significant internal disputes 
that undoubtedly delayed, for instance, the implementation of vaccination 
campaigns and did not help basic research 24. The economic hardship of the 
early years of the Franco regime also contributed to this situation and to 
 22.  Barona; Bernabeu-Mestre, n. 4, p. 295.
 23.  Barona; Bernabeu-Mestre, n. 4, p. 300-301
 24.  For what happened in the serological surveys, see: Ballester; Porras, 2009, n. 7.
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the delayed implementation of specialized care for poliomyelitis patients 25. 
However, eminent figures and groups were active in the country, and Spain 
did take part in another type of event, as we shall discuss below. 
4.	 International	Poliomyelitis	Conferences
4.1.	From	epidemiology	to	vaccination	against	poliomyelitis
The National Foundation for Infantile Paralysis celebrated its tenth anni-
versary by funding the First International Poliomyelitis Conference in New 
York in 1948. The objective was to coordinate and assess the progress made 
by medicine in the study of infantile paralysis during the previous decade. 
The other four conferences took place in Copenhagen (1951), Rome (1954), 
Geneva (1957) and again in Copenhagen (1960). They were all funded by the 
above-mentioned North American organization, under whose auspices the 
International Poliomyelitis Congress was set up. It was entrusted with the 
practical arrangements of the Conferences and was headed by Basil O’Connor, 
president of the National Foundation. The minutes were published by J.B. 
Lippincott 26. The work carried out by the North American organization 
—the National Foundation for Infantile Paralysis— may be considered partly 
comparable to that done by the Rockefeller Foundation (RF), but solely 
in reference to poliomyelitis and rather more limited in time. We could 
therefore say, as some authors have done in interpreting the role of the 
major international agencies —notably the RF and the League of Nations 
Health Organization (LNHO)—, that this organization carried out a simple 
 25.  Báguena; Porras; Ballester, n. 7; Porras, Maria Isabel; Ballester, Rosa. The incorporation of medical 
Technology for the treatment of the acute stage of poliomyelitis in Spain (1940-1965). ESSHC 
(Lisbon, 2008).
 26.  Poliomyelitis. Papers and discussions at the First International Poliomyelitis Conference. Phila-
delphia:  J.B.  Lippincott Company;  1949;  Poliomyelitis.  Papers  and discussions presented at 
the  Second  International  Poliomyelitis  Conference.  Philadelphia:  J.B.  Lippincott  Company; 
1952; Poliomyelitis. Papers and discussions presented at the Third International Poliomyelitis 
Conference. Philadelphia: J.B. Lippincott Company; 1955; Poliomyelitis. Papers and discussions 
presented at the Fourth International Poliomyelitis Conference. Philadelphia: J.B. Lippincott 
Company;  1958;  Poliomyelitis.  Papers  and  discussions  presented  at  the  Fifth  International 
Poliomyelitis Conference. Philadelphia: J.B. Lippincott Company; 1961.
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colonial strategy linked to the interest of American industry 27. However, 
as in the case of the RF and the LNHO, we can add another interpretation 
which also includes the significant benefits 28 brought by the experience of 
polio that this organisation acquired and the resources that it could bring 
for a more effective fight against the epidemics of poliomyelitis and their 
after-effects in Europe. Indeed, apart from the first conference, all of the 
rest were held in European cities that were important both as victims of 
epidemic polio outbreaks and for their traditional position in the field of 
International Health.
There was a gradual change in the subjects covered in the different 
conferences. The first (1948) began its sessions with a talk by Albert Sabin 29 
underlining the importance of polio as a world-wide problem. He described 
the epidemiological patterns of the disease in different parts of the world, 
and provided data on the outbreaks in both rural and urban communities 
in the United States, Sweden and Denmark as well as in different racial 
groups. He emphasized the increase in age of polio victims as one of the 
main results of his research. The pathogenesis, treatment of polio and 
rehabilitation issues were also addressed. In a session on immunology and 
chemotherapy, J. Paul presented the results of his research on the different 
strains of the polio virus, which proved to be fundamental in the subsequent 
development of an anti-polio vaccination 30. In the final session, delegates 
from twenty-eight countries (which did not include Spain 31) gave reports 
on the epidemiological characteristics of polio and the treatments applied 
in their setting 32.
In the second Conference (1951), the session that aroused the liveliest 
debate with the greatest number of contributors was devoted to the diffe-
 27.  As Barona and Bernabeu have pointed out, this interpretation arises from a very simplistic ap-
proach  to  the  complex historical  reality  of  the  inter-war  period.  Barona;  Bernabeu-Mestre, 
n. 4, p. 166.
 28.  On the benefits provide by  the RF and the LNHO, according to Barona and Bernabeu, see: 
Barona; Bernabeu-Mestre, n. 4, p. 166 et seq.
 29.  Sabin, Albert, B. Epidemiological patterns of poliomyelitis in different parts of the world. In: 
Poliomyelitis, 1949, n. 26, p. 3-33.
 30.  Paul, John R. Immunological types of poliomyelitis viruses. In: Poliomyelitis, 1949, n. 26, p. 271-
275.
 31.  On the absence of Spain, we refer to our comments on the WHO.
 32.  Poliomyelitis throughout the world.  In: Poliomyelitis, 1949, n. 26, p. 325-354.
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rential diagnosis of acute poliomyelitis 33. In this session, Robert Debré 
(1882-1978), one of the founders of modern paediatrics and President of the 
French Institut National d’Hygiène, and Stéphane Thieffry concentrated on 
paralytic polio, while Jordi Casals presented a specific complement fixation 
test for the disease, and Jonas Salk gave an immunological classification 
of the polio virus. There were numerous sessions on the treatment and 
ecology of the disease, as well as on virology, with contributions on the 
interactions of the virus with host cells, immunity in polio, the viruses of 
the Coxsackie group and an interesting intervention by J. Enders on the 
growth of the polio virus in human embryo tissue 34.
At the third Conference (1954), studies on physical medicine, re-
habilitation, orthopaedic treatment and the acute phase of polio shared 
the floor with those focused on the social aspects of the disease 35. The 
latter, centred on Italy, the Scandinavian countries and the United States, 
presented the need for the work rehabilitation of polio victims suffering 
from the after-effects of the disease. However, the greatest expectation was 
aroused by the report of J. Salk on the results of his vaccine and A. Sabin’s 
contribution on new inactivated strains of the virus for immunization in a 
session opened by Pierre Lépine, head of the Virus Service of the Institut 
Pasteur, who presented the current epidemiological situation of polio 36. J. 
Enders also attended this congress with his latest work on the development 
of the poliovirus in tissue cultures 37, presented in closed session with the 
projection of a film on the production of the polio virus 38.
At the fourth Conference (1957), there were numerous papers on the 
study of the polio virus and on the different vaccines available, both those 
prepared from deactivated virus (such as those of J. Salk and D. Bodian), 
and those using attenuated virus, most notably those of A. Sabin, H. Ko-
prowski and A. Payne. Extensive time was also devoted to the respiratory 
 33.  Debré, Robert et al. Differential diagnosis in acute poliomyelitis. In: Poliomyelitis, 1952, n. 26, 
p. 157-211.
 34.  Enders, John F. The multiplication and properties of poliomyelitis viruses in cultures on human 
tissue.  In: Poliomyelitis, 1952, n. 26, p. 33-43.
 35.  Cramarossa, Saladino et al. Social aspects of poliomyelitis. In: Poliomyelitis, 1955, n. 26, p. 1-
23.
 36.  Lépine, Pierre R. Infection and immunity in poliomyelitis. In: Poliomyelitis, 1955, n. 26, p. 127-
217.
 37.  Enders, John F. Developments in tissue culture.  In: Poliomyelitis, 1955, n. 26, p. 219-273.
 38.  This film was produced by Connaught Laboratories of Toronto (Canada).
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problems of polio sufferers and their care in special centres or at home, as 
well as the treatment of severe forms of polio. These interventions made 
clear a new challenge, stated by James Wilson in the introduction to this 
session: it was not enough to save the patient’s life; the life saved must be 
as useful as possible 39.
The fifth Conference (1960) did not include any reports from the official 
delegates on the polio situation of their respective countries and was given 
over entirely to the study of the polio virus and the vaccines manufactured as 
a result. Papers on the former dealt with its morphology, chemical structure 
and mutations and with the immunological reactions it causes. Results were 
reported on the application of vaccines with deactivated viruses created in 
the United States, Canada, Denmark and Norway; the highlight was Salk’s 
speech on the duration of the immunity provided by his vaccine 40. The 
results achieved with vaccines produced from attenuated virus were also 
presented, including those of Sabin in Colombia, Costa Rica, Nicaragua and 
the Soviet Union 41. The production of antibodies with this type of vaccine 
led to the participation, among others, of H. Koprowski, H. Cox and Sabin 
himself 42, while the effect of attenuated virus vaccines on the population 
received the attention, among others, of J. Paul 43, whose participation was 
very active throughout these congresses.
4.2.	The	 Spanish	 presence	 and	 its	 repercussions	 in	 the	 daily	 and	
specialized	press
There was Spanish representation in all but the first Conference (1948). 
This Spanish absence went unremarked in the daily press and in the me-
dical journals we have consulted. There was an official delegation at the 
 39.  Wilson,  James L. Care of patients  severely  stricken by poliomyelitis.  Introduction.  In: Polio-
myelitis, 1958, n. 26, p. 470-471.
 40.  Salk, Jonas E. Persistence of immunity following administration of Formalin-Treated Poliovirus 
vaccine.  In: Poliomyelitis, 1961, n. 26, p. 157-175.
 41.  Horwitz, Abraham et al. Attenuated virus vaccine: Experience in field safety and efficacy. In: 
Poliomyelitis, 1961, n. 26, p. 221-278.
 42.  Contreras, Guillermo et al. Attenuated virus vaccine: Antibody response. In: Poliomyelitis, 1961, 
n. 26, p. 279-355.
 43.  Paul, John R. The spread of attenuated polioviruses among household contacts. In: Poliomyelitis, 
1961, n. 26, p. 359-367.
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second Conference (1951), comprising Florencio Pérez Gallardo (1917-
2006), director of the Virology Laboratory of the National School of Health 
and Darío Fernández Iruegas, professor of paediatrics in the Faculty of 
Medicine of Madrid and director of the Hospital-Asylum of San Rafael 
(Madrid). Dario Fernández presented a report on the situation of polio in 
Spain 44. He reported on the 1929 epidemic in Madrid, from where the 
epidemic extended throughout the country. The number of cases did not 
exceed six per 100,000 inhabitants in any province, and its geographical 
distribution remained practically identical every year from 1930 to 1950. 
The behaviour of the disease in Spain contrasted with that observed in the 
rest of Europe. The Spanish epidemic outbreak in 1929 had no equivalent 
in other countries of the continent, where the disease increased between 
1935 and 1940 while it became less frequent in Spain. In 1942, the decrea-
se in the United States and Europe coincided with a rise and subsequent 
fall in Spain, where epidemic outbreaks were detected eight years later in 
Madrid, Valencia, Santander and Pontevedra. The main conclusion of the 
report was that in Spain, as in the rest of the world, polio was tending to 
increase. On this occasion, the daily press did cover the attendance of the 
Spanish delegates at the Copenhagen conference and emphasized the an-
nouncement there of the possible imminent discovery of effective remedies 
to combat the disease 45.
The third Conference (1954) was attended by several Spanish physicians. 
Apparently there was no official delegation, although Juan Bosch Marín, head 
of the Child Health Service of the Dirección General de Sanidad (General 
Health Department), was present. Francisco Barnosell Nicolau, orthopaedic 
surgeon, director of the Institute of Corrective Medicine of Barcelona and 
head of the Central Rehabilitation Service of the Hospital Clínico (Barcelona), 
gave a showing of the film “Physiotherapy and re-education in polio sequela”. 
Bosch Marín intervened in the discussion on respiratory disorders in polio 
due to bulbar involvement in polio and outlined his favourable experience 
 44.  Fernández Iruegas, Darío. Reports of the official delegates. Spain. In: Poliomyelitis, 1952, n. 26, 
p. 149-150.
 45.  La lucha contra la parálisis infantil. Las Provincias. 5 Sep. 1951: 4; La lucha contra la parálisis 
infantil. La Vanguardia. 6 Sep. 1951: 1; Congreso Internacional de Poliomielitis en Copenhague. 
Levante. 8 Sep. 1951: 1.
Spain and the international scientific conferences on polio, 1940s-1960s 
Dynamis 2010; 30: 91-118
107
with the use of respiratory tanks, the only devices available in Spain, as he 
stressed, for the treatment of respiratory complications 46.
In the discussion following the section on physical medicine and 
rehabilitation in polio, mention was made of «A critical examination of 
the Kenny method in the treatment of polio» by Vicente Sanchis Olmos 
(1911-1963), Head of the Orthopaedic and Traumatology Service of the 
Hospital de la Cruz Roja (Madrid) and member of the National Institute 
of Re-education of Invalids in Madrid. His paper studied two of the fac-
tors that might aggravate the acute phase of polio and were under debate: 
irradiation of the medulla with short-wave and with X-rays 47.
The congress was also attended by: the neurologist Ramón Sales 
Vázquez (1971), Chief of the polio service of the Clinical Hospital of Bar-
celona; Francisco Barberá Carré, specialist in functional re-education; the 
paediatrician Darío Fernández Iruegas; and Víctor Meana Negrete, director 
of the National Maritime Sanatorium of Pedrosa (Santander) and director 
of the Hospital-Asylum of San Rafael (Madrid) on the death of Fernández 
Iruegas 48.
The daily press reflected the results of the first vaccinations against polio 
carried out in the United States and announced at this third conference 49. 
La Vanguardia gave it full coverage from its inauguration and, considering 
the different contributions, concluded that there were grounds for cautious 
optimism in the battle against polio, identified as «the disease of civiliza-
tion» 50, because «it increased at the same time as living standards» 51. It 
 46.  Bosch Marín, Juan. Acute medical care in Poliomyelitis. Discussion. In: Poliomyelitis, 1955, n. 
26, p. 105.
 47.  Rosen, Sophus von. Some views on rehabilitation. In: Poliomyelitis, 1955, n. 26, p. 358; p. 362; 
p. 363.
 48.  He organized a Rehabilitation Centre in the National Maritime Sanatorium of Pedrosa (Santander) 
under the auspices of the Health fight against disability (Lucha sanitaria contra la invalidez). 
In  the  same city, he headed  the orthopedic clinic of  the  Infanta Santa Clotilde, belonging 
to the Hermanos de San Juan de Dios.
 49.  III Conferencia Internacional de Poliomielitis en Roma. La Vanguardia. 7 Sep. 1954: 1; Roma está 
especializada en congresos internacionales. Levante. 11 Sep. 1954: 3.
 50.  Congresos internacionales de gran interés. La Vanguardia. 10 Sep. 1954: 10.
 51.  La lucha contra la parálisis infantil. La Vanguardia. 14 Sep. 1954: 11. This article highlighted the 
use in the congress of the latest technological advances, which had enabled the presentation 
in  the  last  session of a photograph of  the poliovirus  taken with an electronic microscope, 
transmitted by television and shown on «a large cinema screen». 
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highlighted the Spanish participation and stressed the importance of the 
success obtained with the vaccine developed by Salk.
There was an official Spanish delegation at the fourth Conference (1957), 
led by Bosch Marín, vice-president of the European Association against Po-
liomyelitis. The scientific delegation was made up of various paediatricians: 
Ciriaco Laguna Serrano (1905-1990), professor of paediatrics from Madrid; 
Antonio Galdó Villegas, professor of paediatrics from Granada; Manuel 
Cruz Hernández, professor of paediatrics from Cádiz; Manuel de la Iglesia 
and Espadaler from the department of paediatrics in Barcelona; and Darío 
Fernández Iruegas, as well as orthopaedic surgeons Francisco Barnosell 
and Esteve de Miguel, functional re-education specialist Francisco Barberá 
Carré; neurologist Ramón Sales Vázquez, Director of the Department of 
Infantile Paralysis of the Hospital Clínico of Barcelona, who also represented 
the Medical Faculty of Barcelona; and José María Sala Ginabreda, from the 
Municipal Hospital of Infectious Diseases in Barcelona 52.
Bosch Marín, in his report on the situation in Spain, emphasized that 
the Payne phenomenon was taking place, with an increased incidence of 
polio in parallel with the improved state of health. There had been more 
than1500 cases annually since 1950, and 91% of cases were in children under 
five years old; the morbidity was virtually identical between small towns 
and cities. He also mentioned the existence of 150 artificial respirators, 
stressed the growing interest in disability as an after-effect of the disease, 
and reported the recent creation of the National Rehabilitation Board 53. 
For his part, the orthopaedic surgeon Esteve de Miguel took part in the 
scientific exhibition of the Conference with a study on precautions against 
the shortening of the lower limbs in paralysed patients 54.
This conference in Geneva received the greatest coverage in the Spa-
nish press yet. It was particularly important because of the reports on the 
 52.  Also present were doctors Quintana, Olaizola, Antonin, Tellería, Roquerro and Martínez.
 53.  Bosch Marín’s speech was not included in the publication of the minutes of this fourth confer-
ence, probably because the text of his report was not sent to the editors, as indicated at the 
end of  the published reports: Reports of Official Delegates.  In: Poliomyelitis, 1958, n. 26, p. 
63. We have a record of this report in the summary of the congress prepared by two of the 
Spanish participants: Cruz Hernández, Manuel. La cuarta Conferencia Internacional sobre la 
poliomielitis. Acta Pediátrica Española. 1957; 15 (177): 727-738 and De la Iglesia, Manuel. La 
cuarta  Conferencia  Internacional  sobre  la  poliomielitis.  Archivos  de  Pediatría.  1957;  8  (45): 
241-246.
 54.  Cruz Hernández, n. 53, p. 737.
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fifty million vaccinations in the United States and on the immunization 
campaigns conducted in Scandinavian countries 55. Bosch Marín attracted 
the attention of the press by announcing that the next assembly of the Eu-
ropean Association was to be held in Madrid in 1958 56, and they reported 
his statements on his return from the congress to the effect that «Polio has 
never been a health problem in Spain», although at the time there was a 
noted tendency for it to increase, as it had in the first three decades of the 
century in all developed countries; he therefore recommended vaccination 
in the future, in line with the other participants in the conference 57.
The fifth Conference (1960) was attended by doctors from the National 
Hospital for Infectious Diseases (Madrid): Juan Figueroa Egea, clinical head, 
and Juan Torres Gost, director of the hospital; specialists in re-education 
and rehabilitation, Argüelles from Madrid, F. Barberá Carré and Luis Portal 
Llamedo from Barcelona; the neurologist Sales Vázquez, and Vicente San-
chis-Bayarri, assistant professor of Public Hygiene and Microbiology from 
Valencia 58. The latter, in his account of the conference, indicated that all 
of the participants had been invited to take part by the Organizing Com-
mittee 59. The publication reporting the minutes of the congress included 
no contribution from the Spanish participants 60.
Among those attending the conferences, the evidence shows that 
among the Spanish representatives there was a majority of paediatricians, 
orthopaedic surgeons, rehabilitation experts and neurologists. Francisco 
Pérez Gallardo, director of the Virology Laboratory of the National School 
of Health (Madrid) and Sanchis-Bayarri, author of pioneering studies in 
Spain on the polio virus were only present at the second and fifth Confe-
rences, respectively 61. The presence of Sanchis-Bayarri indicated a change 
in the trend of the subjects covered at the conferences: studies on clinical 
practice, diagnosis and surgical and orthopaedic treatment lost ground 
 55.  Conferencia  internacional  sobre  la poliomielitis  en Ginebra.  La Vanguardia.  2  Jul.  1957:  14; 
Españoles  en  el  Congreso  Internacional  de  poliomielitis  en  Ginebra.  Las  Provincias.  9  Jul. 
1957: 4; Congreso Internacional de la poliomielitis en Ginebra. Levante. 9 Jul. 1957: 5.
 56.  España en el Congreso Internacional de poliomielitis en Ginebra. La Vanguardia. 9 July 1957: 
4.
 57.  Declaración del Dr. Bosch Marín. Las Provincias. 18 July 1957: 13.
 58.  Doctors Espalder and Foz were also present. 
 59.  Sanchis-Bayarri Vaillant, Vicente. V Conferencia sobre poliomielitis. Medicina Española. 1960; 44: 
338-345.
 60.  There was no news of the conference in the press we have consulted.
 61.  Báguena, n. 7.
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to contributions on the virus and on the different vaccines available to 
prevent the disease. For his part, the presence of Pérez Gallardo in 1951, 
just when Spain was admitted to the WHO, could be interpreted as a clear 
manoeuvre to give political validity to Franco’s regime, represented by a 
competent professional linked to lines of international epidemiological 
research in this field.
5. Symposia of the European Association against Poliomyelitis
Following an initiative of the Belgian Professor L. Laruelle, an assembly 
of epidemiologists, clinicians and researchers was brought together in 
Brussels in 1948, constituting the core of a new group that became the 
European Association against Poliomyelitis, set up in 1951 in Brussels. 
Its first Symposium was held in April 1953 in the Serum Institute of Co-
penhagen 62 and was dedicated to the epidemic in this city from July to 
December of the previous year. This epidemic was the worst that Denmark 
had had ever suffered; its importance was due not only to the number of 
people affected (including paralytic forms) but also to the severity of the 
respiratory problems. These required the generalized use of tracheotomy, 
combined with some methods of controlled respiration derived from 
anaesthesia 63. Between 1953 and 1966, eleven Symposia were held in 
different European cities, every one or two years. The first and second 
Symposium reports were published with the support of the Archives belges 
de médecine sociale, hygiène, médecine du travail et médecine légale   64. 
The first President was P. Lépine (Paris), head of the Virus Service of the 
Institut Pasteur. The other members of the permanent committee of the 
European Association against Poliomyelitis were professors and doctors 
from Copenhagen (Prof. Lassen), Berne (Dr. Vollenweider), London (Dr. 
Bradley, Ministry of Health), Utrecht (Dr. Hemmes), and Brussels (Dr. 
P. Recht). Presidents of Honour were Professor Kling (Sweden) and Dr. 
 62.  This  was  the  National  Serum  Institute,  under  the  Danish Ministry  of  Health.  This  institute 
acted as the central laboratory of the League of Nations Health Organisation in the process 
of standardization during the inter-war period. Barona; Bernabeu-Mestre, n. 4, p. 159.
 63.  This  treatment was  used  as  a  substitute  for  iron  lungs.  Association  Européenne  contre  la 
poliomyélite.  I Symposium Européen de  la Poliomyélite. Copenhague, avril 1953. Bruxelles: 
Éditions Acta Medica Belgica; 1954, p. 7-9.
 64.  Publication related to the Ministère de la Santé Publique et de la famille (1946-1981).
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L. Laruelle (Belgium). According to Lépine, the studies and theories of 
Kling played an important role at the beginning of the renewal of concepts 
of epidemiological and experimental data on polio, and Dr. Laruelle’s 
audacious initiatives were the key to finally achieving the creation of the 
European Association against Poliomyelitis 65.
We can observe a trend in the selection of the topics covered at the 
different Symposia. The first (1953), devoted to the severe Copenhagen polio 
epidemic and active and passive methods of immunization, also provided 
a bibliography published in English, French and German. The number of 
participants in the first and second Symposia was very limited in compa-
rison to the attendance at the following Symposia. The importance and 
severity of this epidemic meant that the main topics were the description 
of the epidemic and its different epidemiological, clinical and therapeutic 
aspects, with special mention of the above-mentioned approaches to 
solving the severe respiratory difficulties. A lack of knowledge on some 
key features of polio and the ways to combating it became clear during 
the discussions on the Copenhagen epidemic; the need was also revealed 
for a closer study of the problem in an organised, scientific and standar-
dised manner to permit comparisons of date from different countries. 
The examination of active and passive immunization methods made 
by professor P. Lépine of the Institut Pasteur of Paris demonstrated the 
development of passive prophylactic measures from 1910 onwards and 
the importance of the introduction of gamma-globulin in 1950 by the 
American, William Hammon. As Lépine explained, he and his collaborators 
had used it extensively under the auspices of the National Foundation 
for Infantile Paralysis, and had noted the success of this method 66. He 
reviewed the history of the active prevention of polio, mentioning the 
three possible methods for obtaining the vaccine; he acknowledged that 
some technical problems remained, but he was confident that a vaccine 
could be available in the near future 67. However, after the interesting 
debate that followed Lépine’s presentation, the European Association 
concluded that «it would be premature to formulate any opinion regar-
ding the value and practicability of vaccination against poliomyelitis in 
 65.  European Association against Poliomyelitis. III Symposium, Zürich, 29-30 September 1955. The 
problem of anti-poliomyelitis vaccinations. Brussels: EAP; 1956, p. 3.
 66.  Association Européenne contre la poliomyélite, n. 63, p. 54-55.
 67.  Association Européenne contre la poliomyélite, n. 63, p. 60.
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the present state of knowledge», and it recommended «that member 
countries should carry out, within the limits of their means, scientific 
and well controlled trials of these methods» 68.
The topic of the second Symposium (1954) was hospitalization from 
all points of view and perspectives, with special attention to treatment in 
the acute stage. For the first time, there was a WHO delegate, Dr. A. Pa-
yne, from the Division of Communicable Disease Services 69. There were 
four sessions dedicated to examining the different problems related to the 
hospitalization of polio patients in the acute stage. A total of eight points 
were discussed: the characteristics of the poliomyelitis hospital centre and 
its place in the general hospital organization of each country; technical and 
material equipment; medical staff, nurses and auxiliaries; the functioning of 
the service; hospital epidemiology; precautions in the case of an epidemic 
or exceptional circumstances; social services for polio patients, and medical 
and social links; and the role of the hospital as a centre for scientific re-
search and specialized training 70. One of the key points was whether polio 
patients in the acute stage should be hospitalized in a special hospital for 
polio victims or in a specialized department of a general hospital. The latter 
course was supported by Robert Debré, president of the French Institut 
National d’Hygiène, creator of the University hospitals and responsible for 
French hospital reform, X. Leclanche and S. Thierry 71.  
At the third Symposium (September of 1955), which was once again 
attended by Dr. Payne, the WHO delegate 72, the question of anti-polio-
myelitis vaccinations was raised for the first time. The early vaccination 
experiences of some European countries (Sweden, Denmark, Germany...) 
were presented, as well as the results of the first studies on the degree of 
anti-poliomyelitis immunity of Italian and Belgian populations 73. The 
brilliant and fascinating speech by Lépine (Le problème des vaccinations 
antipoliomyélitiques et l’appréciation du niveau d’immunité des populations) 
 68.  Association Européenne contre la poliomyélite, n. 63, p. 64.
 69.  Association Européenne contre la poliomyélite. L’hospitalisation des poliomyélitiques à la phase 
aiguë. Recueil des travaux du II Symposium Européen de la Poliomyélite organisé à Paris  le 
8 et 9 avril 1954. Bruxelles: Éditions Acta Medica Belgica; 1955, p. 5.
 70.  Association Européenne contre la poliomyélite, n. 69, p. 5-6.
 71.  Association Européenne contre la poliomyélite, n. 69, p. 12.
 72.  Dr. Payne was the only WHO representative at the majority of these Symposia.
 73.  European Association against poliomyeliis. Third Symposium, Zurich, 29-30 September 1955. 
The problem of anti-poliomyelitis vaccinations. Bruselles: EAP; 1956, p. 7-77.
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provided the general framework for the presentation of particular European 
cases 74. The great importance acquired by vaccination and the subsequent 
debate led to the constitution of a limited commission to set down con-
clusions derived from the different opinions 75. This symposium was also 
devoted to the analysis of the different treatments of poliomyelitis in the 
acute stage, which were studied in all their complexity (the prevention of 
deformities 76, role of aggravating factors, weaning from the iron lung and 
mechanical breathing apparatus).
At the fourth Congress (1956), the main topics were: anti-polio va-
ccination, outbreaks resembling polio, re-education in walking and the 
organisation of a re-education centre, which for the first time played 
a central role. The great majority of the sessions were devoted to this 
subject, and the results of the Symposium, which now had some 200 
delegates from 22 different countries. were compiled in a book entitled 
«Re-education in walking after poliomyelitis», 77. These same topics were 
the key points of the fifth Symposium (1958), although polio vaccination 
regained its prominence 78, and retained it until the eleventh Symposium 
(1966), although it was becoming progressively more complex. In the 
fifth Symposium (Madrid, 1958), the WHO was represented not only 
by Dr. Payne but also by the Spaniard Dr. F. Pérez Gallardo, as delegate 
of the Europe Regional Office 79.
For the first time, vaccination by attenuated living viruses was one of 
the key points of the sixth Symposium (1959), in which Albert Sabin spoke 
on the «Present status of field trials with an oral, live, attenuated poliovirus 
vaccine» 80, which was a summary of the article he had published in the 
JAMA in June of the same year. From the sixth Symposium onwards, we 
 74.  European Association against Poliomyelitis, n. 73, p. 7-23.
 75.  European Association against Poliomyelitis, n. 73, p. 5.
 76.  The third Symposium also paid considerable attention to the prevention of deformities. See: 
European Association against Poliomyelitis, n. 73, p. 127-168.
 77.  European  Association  against  Poliomyelitis.  Re-education  in walking  after  Poliomyelitis.  IV 
Symposium, Bologna, 20-22 September 1956. Brussels: EAP; 1957.
 78.  European Association against Poliomyelitis. Vaccination and immunity. Neurophysiological and 
neuropathological  aspects  of  poliomyelitis. V  Symposium, Madrid,  28-30  September  1958. 
Brussels: EAP; 1959.
 79.  European Association against Poliomyelitis, n. 78, p. 3.
 80.  European Association against Poliomyelitis. Anti-poliomyelitis vaccinations. Physio-Pathology 
of  the  respiratory disorder. Poliomyelitis of  the «very young child». VI Symposium, Munich, 
7-9 September 1959. Brussels: EAP; 1960.
María Isabel Porras, María José Báguena and Rosa Ballester
Dynamis 2010; 30: 91-118
114
can see the presence of a «Virological Group» as well as an «Orthopaedic 
Group», together with a more important role for respiratory disorders. 
These tendencies continued in the seventh (1961) 81 and eighth (1962) 82 
Symposia,  when the different aspects of vaccination and virological problems 
became the key points, relegating physiological and clinical problems to a 
secondary role. As we shall see, the importance acquired by virology was 
also evidenced by the incorporation of Spanish groups from the National 
Virus Centre, who made some excellent contributions in the eleventh 
Symposium 83.
5.1	 Spanish	participation
There was an official Spanish delegation (including Bosch Marín) from 
the second Symposium onwards. Bosch Marín was elected as one of the 
Vice-Presidents of the Association at the General Assembly of 1 October 
1955. He was chosen as delegate due to his position as Director of Central 
Services of Infant Hygiene of the General Board of Health of the Interior 
Ministry. From the fifth until the ninth Symposia, Bosch Marín reported 
data on poliomyelitis morbidity and mortality in Spain and on the different 
measures adopted (or rather planned to adopt) in our country against the 
disease and its after-effects. In the eleventh Symposium (1964), the official 
Spanish delegation was chosen from among polio experts of the National 
Virus Centre (Centro Nacional de Virus de Majadahonda) of the General 
Board of Health. This change showed the importance acquired by experts 
and virology in the fight against poliomyelitis.
Spanish scientific participation started at the third Symposium (1955) 
with the neurologist Sales Vázquez and the paediatrician M. de la Iglesia 
from the Paediatric Clinic of the University of Barcelona, who recounted 
 81.  European  Association  against  Poliomyelitis.  Programmes  of  vaccination.  Encephalitis  and 
meningitis in enteroviral infections. Virological and clinical problems. VII Symposium, Oxford, 
17-20 September 1961. Brussels: EAP; 1962.
 82.  European Association against Poliomyelitis. Vaccination and Epidemiology of poliomyelitis and 
allied diseases. New developments in the programmes of vaccination. Clinical problems. VIII 
Symposium, Prague, 23-26 September 1962. Brussels: EAP; 1963.
 83.  European Association against Poliomyelitis. Epidemiology of poliomyelitis in Europe. Problems 
of vaccinations and virological studies. Surgical treatments and rehabilitation. XI Symposium, 
Rome, 9-12 October 1966. Brussels: EAP; 1967, p. 102-109.
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their experience with the treatment of poliomyelitis in the acute phase 
and with hibernation and neuroplegic drugs during the 1954 epidemic in 
Catalonia 84. No paper was presented by a Spaniard at the fourth Sympo-
sium. Spanish scientific participation took on greater importance at the 
fifth Symposium in Madrid in 1958. Indeed, as might be expected, this 
was the Symposium with the greatest Spanish participation, and it was 
extensively covered by the press, especially the Madrid press 85. Their 
contributions centred on the prevention of deformities and different 
aspects of the rehabilitation of polio victims and were reported with all 
of the other contributions but in a separate volume 86. This Symposium 
was attended by: physicians from the National Hospital for Infectious 
Diseases, J. Torres Gost, Director, J. Figueroa Egea, Clinical Head and 
J. Salvia Torres, Intern; traumatologists Bernardo E. Múgica from the 
Hospital de la Paz (Madrid), Álvaro López Fernández and José E. Ba-
taller Sallée from the National Maritime Sanatorium «La Malvarrosa» 
(Valencia) and Vicente Sanchis Olmos; surgeons Francisco Martín Lagos, 
Professor of the Medical Faculty of Madrid and J. Trochuelo Negrete 
from the Hospital-Asylum of San Rafael; rehabilitation specialists R. 
Sales Vázquez and C. Ballús Pascual, from the Department of Poliomye-
litis Rehabilitation of the Provincial Office of Health, Provincial Clinical 
Hospital of Barcelona; Heliodoro Ruiz García, Director of the Cabinet of 
Physical Medicine and Re-education of Madrid; the Paediatric Professor 
C. Laguna, Member of the Foundation for the Fight against Poliomyelitis 
and Director of the National School of Puericulture (Madrid); and Dr. 
Martín Ongil González, Service of General Medicine of the Compulsory 
Health Insurance of Madrid 87.
The Sixth Symposium was attended only by the neurologist R. Sales 
Vázquez and by L. Portal from the Centre for Poliomyelitis Rehabilitation of 
the Provincial Office of Health, Faculty of Medicine and Clinical Hospital 
 84.  European Association against Poliomyelitis, n. 73, p. 116-117.
 85.  As  indicated  in another paper,  coverage was more exhaustive  in  the Madrid press  than  in 
Valencia: Porras, María-Isabel;  Báguena, María-José.  La poliomielitis en  la España  franquista 
a través de la prensa general (1940-1975).  In: Ortiz, Teresa et al., coords., n. 7, p. 324-329.
 86.  Aportación española al V Symposium europeo sobre poliomielitis. Madrid, 28-30 September 
1958. Madrid:  Publicaciones  «Al  servicio  del  niño  español»,  Ministerio  de  la  Gobernación; 
1958.
 87.  The following doctors from Madrid took part in this Symposium: Doctors Alemany, R. Escu-
dero, F. León, Vicente Giménez, and Luis Gómez Barnuevo.
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of Barcelona. The former also took part in the seventh Symposium. There 
was no Spanish presence in the scientific sessions at either the eighth or 
ninth Symposia. At the tenth Symposium (1964), Drs. F. Pérez Gallardo, 
L. Valenciano and J. Gabriel y Galán from the National Virus Centre of 
Madrid presented the results of the first mass vacination campaign against 
poliomyelitis with Sabin’s oral vaccine, which had taken place between the 
end of 1963 and the spring of 1964 88. Drs. L. Valenciano, J. Gabriel y Galán 
and F. Pérez Gallardo from the National Virus Centre of Madrid presented 
an interesting new study on the epidemiology of poliomyelitis in Spain 
during 1965 and the first six months of 1966 at the eleventh Symposium 
(1966) 89.
Apart from the special case of the fifth Symposium, when there were 
more Spanish participants from different specialities such as Paediatrics, 
Rehabilitation, Surgery, and General Practice, the Spanish presence in Eu-
ropean Symposia was consistently provided by representatives from Surgery 
and Rehabilitation and, until the tenth Symposium, from Paediatrics. At 
that point, the presence of researchers from the National Virus Centre 
(Majadahonda) led to some extremely modern and professional papers, 
which were very different from the contributions made by Bosch Marín 
from the middle of the 1950s until 1963.
6.	 Concluding	remarks	
Polio, as an important and worrying worldwide problem, was included 
in the international public health agenda from the 1940s onwards. The 
main sources for the study of the contents of polio-related international 
health policies are the World Polio Congresses, the Reports of the Expert 
Committee on Poliomyelitis of the World Health Organization and the 
Symposia promoted by the European Association against Poliomyelitis. The 
International Polio Conferences were funded by the National Foundation 
of Infantile Paralysis, a very important private organization promoted by 
President Roosevelt of the USA. In the case of European conferences, they 
 88.  European Association against Poliomyelitis. Reactions and complications after oral vaccination. 
Problems of  the  immunity and virological studies. Problems of  reeducation. X Symposium, 
Warsaw, 4-7 October 1964, Brussels: EAP; 1965, p. 91-98.
 89.  European Association against Poliomyelitis, n. 83, p. 102-109.
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retained the prototype profile of an association of scientists interested in 
sharing their experiences and research.
The connection of the WHO with European and worldwide initiatives 
was evident from the very beginning of their operations, which had the 
support of the WHO. This explains why, despite the diverse origins and 
aims of the organisations (although they shared the common goal of the 
highest possible level of international coordination in the struggle against 
polio), the degree of synergy among them was considerable. Several leading 
experts were present in the activities of all three, including the virologist 
Lépine, the epidemiologists Payne and Albert Sabin, and the Spanish epi-
demiologist and virologist Pérez Gallardo.
Parallel trends can be observed over this period in the topics considered 
by the three organizations: from general epidemiological aspects at the first 
meetings, which sought to establish the dimensions of the polio problem 
worldwide, to updating delegates on virological and immunity research. 
The number one subject from the mid-1950s was undoubtedly the two 
aspects of vaccination: 1) the debate on the advantages and drawbacks of 
the two main types: Salk’s inactivated polio vaccine (IPV) and Sabin’s live 
attenuated vaccine (OPV), and 2) the experiences of mass immunization 
with either vaccine in different countries. Other questions, such as treatment 
in the acute phase, physical therapy, orthopaedic apparatus and rehabilita-
tion from sequelae, also found their place on the agenda of international 
organisations and meetings.
In terms of Spanish participation in the international arena, Spain was 
completely absent from the WHO until 1958, although the recommendations 
of the experts were widely quoted by health authorities and professionals 
and researchers. Moreover, the organisation did on occasions have delegates 
acting as advisers in Spain.
In the case of the International and European congresses, there were 
three types of participation. The first was more political: the primary aim 
was to win points for an unpopular totalitarian regime in the international 
community by reporting activities and results that often existed only on 
paper and did not reflect reality, e.g., on the number of iron lungs in Spain or 
the number of children vaccinated, very difficult to verify, and on the types 
of campaign. The second involved paediatricians, orthopaedic experts, and 
rehabilitation professionals who described their experience in the treatment 
of polio and its sequelae. Most of these professionals were involved in the 
implementation of the different services created by the Dirección General de 
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Sanidad (General Health Department), the Compulsory Health Insurance 
Scheme or the hospitals run by religious orders to deal with the problem 
of polio in Spain. Finally, there was the high-level scientific participation 
of researchers connected to leading groups in the international arena in 
the fields of virology and epidemiology, such as the National Virus Centre 
group or the Sanchis-Bayarri team in Valencia.
The more political profile of the 1940s and 1950s changed from the 
1960s onwards, coinciding with the political and social transformations and 
economic improvements in Spain 90. It reflected the standards of profes-
sional scientists with a prestigious technical profile who announced their 
results in international forums as experts, ignoring all national political 
connotations. Without the information which may be provided by ongoing 
research, we may state that the participation of experts in the international 
forums studied here may be considered to have a double purpose: support 
and legitimization of the dictatorial political regime, but also an opportunity 
for these experts to obtain international backing and recognition, paving 
the way for them to achieve improvements in their own country. A clear 
example of this double role was that of Florencio Pérez Gallardo: he served 
the regime as a member of the official delegation to the Second International 
Conference (1951) but he also received international recognition, as WHO 
delegate at the V Symposium (1958) and later as Spanish representative to 
the European Association against Poliomyelitis, which led to improvements 
in his Virology Laboratory in the National Health School 91. z
 90.  On the political, social and economic changes taking place in Spain in the 1960s, see: Mora-
diellos, Enrique. La España de Franco (1939-1975). Política y sociedad. Madrid: Síntesis; 2003, 
p. 95-136; Martínez, J., coord. Historia de España siglo XX, 1939-1996. 2ª ed. Madrid: Cátedra; 
2003.
 91.  Ballester; Porras, 2009, n. 7.
